Videos | HRS
VIDEO: Top New EP Technologies at Heart Rhythm Society 2020

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

Home May 22, 2020
Home
Videos | Cardiovascular Education
VIDEO: Insights Into How HRS Organized its Virtual Meeting

Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, professor of medicine at the ...

Home May 22, 2020
Home
SCAI Announces 2020 Late-breaking Clinical Studies, featured clinical research sessions. #SCAI2020
Feature | SCAI
SCAI Announces 2020 Late-breaking Clinical Studies

May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the ...

Home May 21, 2020
Home
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020
News | Congenital Heart
Medtronic Congenital Heart Transcatheter Valve Studies Show Strong Results in SCAI Late-breakers

May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were ...

Home May 21, 2020
Home
Rash on the skin of a child who has COVID-19 related multi-system inflammatory syndrome (MIS-C). Image copyright Damien Bonnet, M.D., Ph.D., courtesy of the American Heart Association. Coronavirus is linked with this Kawasaki-like inflammatory disease in children. #MIS-C #COVID #COVIDinkids #COVIDinChildren
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
Kawasaki-like Inflammatory Disease Affects Children With COVID-19

A new, serious COVID-19 cardiovascular presentation emerged in late April and early May 2020 in the form of pediatric ...

Home May 20, 2020
Home
HRS 2020 Late-Breaking Clinical Trials in Electrophyiology
Feature | HRS
Heart Rhythm Society 2020 Late-Breaking Clinical Trials in Electrophysiology

May 20, 2020 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them ...

Home May 20, 2020
Home
he Actus AcQMap EP 3-D mapping catheter used to speed electromapping and procedure times.
News | EP Lab
Biotronik Partners With Acutus Medical to Offer More Efficient Arrhythmia Diagnosis and Treatment

May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of ...

Home May 20, 2020
Home
PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell
News | Atrial Fibrillation
Heart Tissue Changes Can Predict Atrial Fibrillation Prior to Onset

May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the ...

Home May 19, 2020
Home
Results of the Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study at HRS 2020. #HRS2020 #Heartrhythm2020,
News | Atrial Fibrillation
Atrial Fibrosis Predicts Recurrent Stroke or New AF Onset 

May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking ...

Home May 19, 2020
Home
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
News | EP Lab
Thermedical SERF Ablation System Earns FDA Breakthrough Device Designation 

May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT) ...

Home May 19, 2020
Home
A list of all the abnormalities the AI model classifies. This illustration only shows three representative leads (DII, V1 and V6).Fig. This is Figure 1 from the Nature Communications article.
News | Artificial Intelligence
AI Tool Allows Automated ECG Interpretation for Cardiac Diagnostics

May 19, 2020 — Artificial intelligence (AI) may be an aid to interpreting ECG results, helping healthcare staff to ...

Home May 19, 2020
Home
Mayo Clinic is using artificial intelligence EchoGo Core software from Ultromics to automatically analyize echocardiography images to assess the cardiac impact of COVID-19. The AI software is from Ultromics.
News | Coronavirus (COVID-19)
Mayo Clinic Uses Artificial Intelligence to Help Assess Cardiac Danger From COVID-19

May 19, 2020 — A joint U.K.-U.S. research team is applying a pioneering artificial intelligence (AI) system to ...

Home May 19, 2020
Home
Videos | Coronavirus (COVID-19)
VIDEO: Overview of Hydroxychloroquine and FDA Warning in its use to Treat COVID-19

Marianne Pop, Pharm.D., BCPS, a clinical pharmacist and clinical assistant professor with the regional pharmacy program ...

Home May 18, 2020
Home
Edwards Lifesciences Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe
News | Heart Valve Technology
Edwards Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe

May 18, 2020 — The Edwards Lifesciences Corp. Pascal tricuspid transcatheter valve repair (TTVR) system received ...

Home May 18, 2020
Home
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab
Eating Prior to Cardiac Cath Noninferior to Fasting in CHOW NOW Study 

May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or ...

Home May 18, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now